Newsletter | October 8, 2026

10.08.26 -- Regulatory Readiness From Phase I Onward

SPONSOR

 

 

Join our webinar on October 22, 2026, at 11 AM ET to learn how to successfully execute adaptive trials. We will explore key impacts on sites, data, technology, supply, and teams. Don't let adaptation turn into disruption—register today to secure your spot! Registration is free.

OUTSOURCING MODELS

 

With CROs, Decide What You Can Actually Manage

Industry veteran Peter Fredette explores how small biotechs can rethink CRO outsourcing by balancing cost, operational needs, and internal oversight. Before choosing a CRO model, sponsors must honestly assess which services they need — and how many partners they can realistically manage.

 

Flying On Two Wings: Local Agility And Global Quality In China

As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.

 

Vendor Disruption Doesn't Have To Derail Your Clinical Trial

When vendors face disruptions, trials can be affected. Discover key questions to assess partner stability, strengthen operational resilience, and keep studies on track.

 

Why Cost Of Delivery, Not Rate, Is The Lever CROs Actually Control

This piece breaks down why Agentic AI monitoring, nearly a third of trial cost, resets the economics, and why the first CRO to move first resets the price floor for everyone else.

 

Advancing Analgesic Development With Validated Pain Models

Explore validated pain models and integrated early-phase services designed to characterize dose response, evaluate safety and efficacy, and support informed decisions in analgesic development.

 

Importer Of Record (IOR) Services For Clinical Trials

Global clinical trials face customs challenges. A synchronized Importer of Record service ensures compliance, streamlines logistics, and helps prevent shipment delays.

SPONSOR

 

Webinar: What’s Working in AI-Enabled Respiratory Trials: From Recruitment to Site Readiness

Respiratory clinical trials face growing challenges, from shrinking patient populations and complex protocols to competition for patients and sites. How can AI and digital solutions help? This webinar explores practical approaches to optimize study design, predict enrollment, reduce participant burden and detect emerging risks earlier. Discover how technology can support efficient, patient-centric trials while strengthening quality and execution. Click here to learn more.

REGULATORY COMPLIANCE

 

Repurposing Three FDA-Approved Drugs For A New Stroke Recovery Strategy

When three drugs become one — the polypharmacology strategy, 505(b)(2) pathway, and objective endpoints Nuero-Innovators is relying on to bring new hope to stroke patients.

 

UK Clinical Trial Regulations Reform

UK trial regulations have been overhauled. Learn what faster approval pathways, stricter publication rules, and longer retention requirements mean for your operations.

 

Pharmacy Considerations For Early Phase Trials

This presentation explores practical pharmacy considerations in early-phase clinical trials, offering real-world insights from experienced clinical research pharmacists.

 

GLP Compliance In A Modern Lab: What Is Actually Required?

GLP compliance isn’t binary. Real defensibility depends on rigorous QA, validated electronic systems, and operational maturity — not just a label.

 

Why Early CRO Choice Is Critical To Accelerating Your Delivery

Regulatory readiness for global expansion begins in Phase I. A development partner should design your trial and data collection to anticipate downstream regulatory requirements in your target regions.

 

How Modern Logistics Support Belmont And HHS OIG Goals

Participant support can expand trial access, but regulatory uncertainty limits adoption. A safe harbor could enable reimbursement and compensation while protecting against coercion and undue influence.

 

Human ADME Studies: Human Metabolism Data

Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.

 

EU Clinical Trial Compliance: De-Risking CTR & CTIS

This essential guide walks through mastering the complex landscape of clinical trial regulations, providing a clear, practical breakdown of regulatory timelines, legal obligations, and more.

Connect With Clinical Leader: